Sotabase

Career

· Donovan Family Professor of Computer Science; Provost's Senior Faculty Teaching Scholar, Columbia University2017–
· C. Lester Hogan Professor of Electrical Engineering and Computer Science, University of California, Berkeley1996–2017
· Professor, National Technical University of Athens1981–1988
· Ph.D. in Electrical Engineering and Computer Science, Princeton University1976–
· BS in Electrical Engineering, National Technical University of Athens1972–

Publications (245)

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Journal of Clinical Oncology · 2005
1,184
cited
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.
The Lancet Oncology · 2008
750
cited
Thalidomide and dexamethasone combination for refractory multiple myeloma.
Annals of Oncology · 2001
292
cited
Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications.
Cancer Treatment Reviews · 2012
210
cited
Trastuzumab administration during pregnancy: a systematic review and meta-analysis
Breast Cancer Research and Treatment · 2012
145
cited
Hormonal Therapy with Letrozole for Relapsed Epithelial Ovarian Cancer
Oncology · 2004
130
cited
Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC)
Cancer · 2011
113
cited
Information Science
Nature · 1971
108
cited
Taxanes for breast cancer during pregnancy: a systematic review.
Clinical Breast Cancer · 2013
108
cited
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of Oncology · 2005
97
cited
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study
Breast Cancer Research and Treatment · 2012
96
cited
The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality.
Cancer Treatment Reviews · 2018
92
cited
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
British Journal of Cancer · 2013
90
cited
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of Clinical Oncology · 1999
90
cited
Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum‐paclitaxel chemotherapy
Cancer · 2010
88
cited
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of Oncology · 2004
78
cited
Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.
Atherosclerosis · 2011
73
cited
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
Annals of Oncology · 2005
72
cited
Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
Pharmaceuticals · 2012
68
cited
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group.
Annals of Oncology · 2002
65
cited
Sotabase